J&J COVID-19 booster cuts Omicron hospitalizations by 84%, study suggests
The real-world study was based on a second dose of the Johnson & Johnson vaccine administered to 69,092 workers between Nov. 15 and Dec. 20.
Tomas Kauer - Moderator 
The real-world study was based on a second dose of the Johnson & Johnson vaccine administered to 69,092 workers between Nov. 15 and Dec. 20.
